Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors

BMJ. 2002 Jul 20;325(7356):161; author reply 161.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Celecoxib
  • Cell Division / drug effects
  • Cyclooxygenase Inhibitors / pharmacology*
  • Humans
  • Lactones / pharmacology*
  • Pyrazoles
  • Sulfonamides / pharmacology*
  • Sulfones
  • Tumor Cells, Cultured

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents
  • Cyclooxygenase Inhibitors
  • Lactones
  • Pyrazoles
  • Sulfonamides
  • Sulfones
  • rofecoxib
  • Celecoxib